Fertility preservation in women with cancer and afterward

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7–30
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Cancer in Australia 2017. February 3 2017. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2017
   Google Scholar
• Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med 2017;377:1657–65
   PubMed Web of Science ®Google Scholar
• Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141–54
   PubMed Web of Science ®Google Scholar
• Vollenhoven B, Hunt S. Ovarian ageing and the impact on female fertility. F1000Research 2018;7:1835
   PubMedGoogle Scholar
• Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol 2016;12:2333–44
   PubMed Web of Science ®Google Scholar
• Codacci-Pisanelli G, Del Pup L, Del Grande M, Peccatori FA. Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients. Crit Rev Oncol/Hematol 2017;113:90–6
   PubMed Web of Science ®Google Scholar
• Bedoschi G, Turan V, Oktay K. Utility of GnRH-agonists for fertility preservation in women with operable breast cancer: is it protective? Curr Breast Cancer Rep 2013;5:302–8
   PubMedGoogle Scholar
• Lee SJ, Schover LR, Partridge AH. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. JCO 2006;24:2917–31
   PubMed Web of Science ®Google Scholar
• Levine JM, Kelvin JF, Quinn GP, Gracia CR. Infertility in reproductive-age female cancer survivors. Cancer 2015;121:1532–9
   PubMed Web of Science ®Google Scholar
• Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol 2010;116:1171–83
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Instit Monogr 2005; 2005:64–8
   Google Scholar
• Marci R, Mallozzi M, Di Benedetto L. Radiations and female fertility. Reprod Biol Endocrinol 2018;16:112
   PubMed Web of Science ®Google Scholar
• Falcone T, Moore HC. GnRH agonist for gonadal protection during chemotherapy. Hum Reprod 2015;30:2711–12
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Ceppi M, Poggio F. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treatment Rev 2014;40:675–83
   PubMed Web of Science ®Google Scholar
• Senra JC, Roque M, Talim MCT, Reis FM, Tavares R. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018;51:77–86
   PubMed Web of Science ®Google Scholar
• Hickman LC, Llarena NC, Valentine LN, Liu X, Falcone T. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists. J Assist Reprod Genet 2018;35:571–81
   PubMed Web of Science ®Google Scholar
• Oktay K, Harvey BE, Partridge AH. Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update. JCO 2018;36:1994–2001
   PubMed Web of Science ®Google Scholar
• Martinez F, Andersen CY, Barri PN, et al. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril 2017;108:407–15.e11
   PubMed Web of Science ®Google Scholar
• Christianson MS, Lindheim SR. Pediatric ovarian tissue cryopreservation: time to lift the experimental label? Fertil Steril 2018;109:805–6
   PubMed Web of Science ®Google Scholar
• Gellert SE, Pors SE, Kristensen SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet 2018;35:561–70
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med 2018;378:400–1
   PubMed Web of Science ®Google Scholar
• Donnez J, Martinez-Madrid B, Jadoul P, et al. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 2006;12:519–35
   PubMed Web of Science ®Google Scholar
• Bjelland EK, Wilkosz P, Tanbo TG, Eskild A. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 Survey). Hum Reprod 2014;29:835–41
   PubMed Web of Science ®Google Scholar
• Wilkosz P, Greggains GD, Tanbo TG, Fedorcsak P. Female reproductive decline is determined by remaining ovarian reserve and age. PloS One 2014;9:e108343
   PubMed Web of Science ®Google Scholar
• Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod 2013;28:2996–9
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Diaz C, Pellicer A. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril 2015;104:1097–8
   PubMed Web of Science ®Google Scholar
• Forman EJ. Ovarian tissue cryopreservation: still experimental? Fertil Steril 2018;109:443–4
   PubMed Web of Science ®Google Scholar
• Rienzi L, Gracia C, Maggiulli R, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update 2017;23:139–55
   PubMed Web of Science ®Google Scholar
• Rienzi L, Ubaldi FM. Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women's autonomy. J Assist Reprod Genet 2015;32:1195–6
   PubMed Web of Science ®Google Scholar
• Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril 2003;80:116–22
   PubMed Web of Science ®Google Scholar
• Benard J, Duros S, El Hachem H, et al. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art. Future Oncol 2016;12:1731–41
   PubMed Web of Science ®Google Scholar
• Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 2013;100:1673–80
   PubMed Web of Science ®Google Scholar
• Kuang Y, Chen Q, Hong Q, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online 2014;29:684–91
   PubMed Web of Science ®Google Scholar
• Ubaldi FM, Capalbo A, Vaiarelli A, et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril 2016;105:1488–95.e1
   PubMed Web of Science ®Google Scholar
• Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 2013;100:1681–5.e1
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. JCO 2005;23:4347–53
   PubMed Web of Science ®Google Scholar
• Oktay K, Türkçüoğlu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010;20:783–8
   PubMed Web of Science ®Google Scholar
• Cobo A, García-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016;105:755–64.e8
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Marotta ML, Pirard C, Donnez J, Donnez O. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res 2014;7:80
   PubMed Web of Science ®Google Scholar
• Ernst E, Kjaersgaard M, Birkebaek NH, Clausen N, Andersen CY. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer 2013;49:911–14
   PubMed Web of Science ®Google Scholar
• Poirot C, Abirached F, Prades M, et al. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 2012;379:588
   PubMed Web of Science ®Google Scholar
• Demeestere I, Simon P, Dedeken L, et al. Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod 2015;30:2107–9
   PubMed Web of Science ®Google Scholar
• Ladanyi C, Mor A, Christianson MS, Dhillon N, Segars JH. Recent advances in the field of ovarian tissue cryopreservation and opportunities for research. J Assist Reprod Genet 2017;34:709–22
   PubMed Web of Science ®Google Scholar
• Irene Su H, Lee YT, Barr R. Oncofertility: Meeting the Fertility goals of adolescents and young adults with cancer. Cancer J 2018;24:328–35
   PubMed Web of Science ®Google Scholar
• Lambertini M, Del Mastro L, Pescio MC. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016;14:1
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Azim HA, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24: vi160–70
   PubMed Web of Science ®Google Scholar